Top Clinical Trials companies in Saudi Arabia by EBIT Margin
This ranking features the top 1 Clinical Trials companies in Saudi Arabia ranked by EBIT Margin, averaging a EBIT Margin of 5.77%, for February 11, 2025.
Saudi Arabia
Clinical Trials
EBIT Margin
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
5.77%
|
Dec. 31, 2023 | USD 8.71 | -0.52% |
|
Saudi Arabia |
Frequently Asked Questions
-
Which Clinical Trials company in Saudi Arabia has the highest EBIT Margin ?
The Clinical Trials company in Saudi Arabia with the highest EBIT Margin is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at 5.77%.
-
Which Clinical Trials company in Saudi Arabia has the lowest EBIT Margin ?
The Clinical Trials company in Saudi Arabia with the lowest EBIT Margin is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at 5.77%.
-
What are the top 10 Clinical Trials companies in Saudi Arabia by EBIT Margin ?
The top 10 Clinical Trials companies in Saudi Arabia by EBIT Margin are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
-
What are the bottom 10 Clinical Trials companies in Saudi Arabia by EBIT Margin ?
The bottom 10 Clinical Trials companies in Saudi Arabia by EBIT Margin are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
